Artes Medical Announces Pricing for Initial Public Offering.

SAN DIEGO -- Artes Medical, Inc. today announced the pricing of its initial public offering of 4,600,000 shares of common stock at a price of $6.00 per share. All of the shares are being offered by Artes Medical. Artes Medical's shares of common stock will be listed on the NASDAQ Global Market under the trading symbol "ARTE."

Cowen and Company, LLC and Lazard Capital Markets LLC are acting as joint book-running managers for the offering, and Stifel, Nicolaus & Company, Incorporated is acting as a co-manager for the offering. Artes Medical has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares of common stock to cover over allotments, if any.

The public offering is being made only by means of a prospectus. Copies of the final prospectus relating to the offering can be obtained from the Cowen and Company, LLC Prospectus Department or from the Lazard Capital Markets LLC Prospectus Department, each at ADP, 1155 Long Island Avenue, Edgewood, New York 11717, phone number [phone].

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on December 19, 2006. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Artes Medical, Inc.

Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets. The Company's initial product, ArteFill[R], is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as nasolabial folds, or smile lines, which is being marketed as a treatment for men and women. Additional information about Artes Medical and ArteFill is available at www.artesmedical.com and www.artefill.com.

Forward-Looking Statements

This news release may contain forward-looking statements that are based on the Company's current beliefs and assumptions and on information currently available to its management. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. As a result of these risks, uncertainties and other factors, readers are cautioned not to place undue reliance on any forward-looking statements included in this press release. These forward-looking statements represent beliefs and assumptions only as of the date of this news release, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.

Artes Medical[R] and ArteFill[R] are registered trademarks of Artes Medical, Inc.